• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T=4 二十面体 HIV-1 衣壳作为 HIV-1 V3 环表位展示的免疫原性载体。

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display.

机构信息

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China.

National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Sciences, Xiamen University, Xiamen 361102, China.

出版信息

Viruses. 2018 Nov 26;10(12):667. doi: 10.3390/v10120667.

DOI:10.3390/v10120667
PMID:30486318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6316451/
Abstract

The HIV-1 mature capsid (CA) assumes an amorphous, fullerene conical configuration due to its high flexibility. How native CA self-assembles is still unclear despite having well-defined structures of its pentamer and hexamer building blocks. Here we explored the self-assembly of an engineered capsid protein built through artificial disulfide bonding (CA N21C/A22C) and determined the structure of one fraction of the globular particles. CA N21C/A22C was found to self-assemble into particles in relatively high ionic solutions. These particles contained disulfide-bonding hexamers as determined via non-reducing SDS-PAGE, and exhibited two major components of 57.3 S and 80.5 S in the sedimentation velocity assay. Particles had a globular morphology, approximately 40 nm in diameter, in negative-staining TEM. Through cryo-EM 3-D reconstruction, we determined a novel T = 4 icosahedral structure of CA, comprising 12 pentamers and 30 hexamers at 25 Å resolution. We engineered the HIV-1 V3 loop to the CA particles, and found the resultant particles resembled the morphology of their parental particles in TEM, had a positive reaction with V3-specific neutralizing antibodies, and conferred neutralization immunogenicity in mice. Our results shed light on HIV CA assembly and provide a particulate CA for epitope display.

摘要

HIV-1 成熟衣壳(CA)由于其高灵活性而呈现出无定形的富勒烯锥形构象。尽管其五聚体和六聚体构建块具有明确的结构,但天然 CA 如何自我组装仍然不清楚。在这里,我们通过人工二硫键构建探索了一种工程化衣壳蛋白(CA N21C/A22C)的自组装,并确定了球形颗粒的一部分的结构。CA N21C/A22C 被发现可以在相对高离子溶液中自组装成颗粒。这些颗粒通过非还原 SDS-PAGE 确定含有二硫键连接的六聚体,并在沉降速度测定中表现出 57.3 S 和 80.5 S 的两个主要成分。颗粒在负染色 TEM 中具有球形形态,直径约为 40nm。通过冷冻电镜 3-D 重建,我们确定了 CA 的一种新型 T = 4 二十面体结构,包含 12 个五聚体和 30 个六聚体,分辨率为 25Å。我们将 HIV-1 V3 环工程化到 CA 颗粒上,发现所得颗粒在 TEM 中与亲本颗粒的形态相似,与 V3 特异性中和抗体呈阳性反应,并在小鼠中赋予中和免疫原性。我们的结果阐明了 HIV CA 组装,并提供了用于表位展示的颗粒状 CA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/1e9f58ad3b1e/viruses-10-00667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/fda81a3e156e/viruses-10-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/3189317ddcbf/viruses-10-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/f9928a745784/viruses-10-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/04bec89bd31a/viruses-10-00667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/1e9f58ad3b1e/viruses-10-00667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/fda81a3e156e/viruses-10-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/3189317ddcbf/viruses-10-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/f9928a745784/viruses-10-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/04bec89bd31a/viruses-10-00667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23fa/6316451/1e9f58ad3b1e/viruses-10-00667-g005.jpg

相似文献

1
T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display.T=4 二十面体 HIV-1 衣壳作为 HIV-1 V3 环表位展示的免疫原性载体。
Viruses. 2018 Nov 26;10(12):667. doi: 10.3390/v10120667.
2
Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.兔抗 HIV-1 gp120 第三可变环(V3)区抗体结构揭示抗原表位复杂度增加与抗体亲和力成熟及新结合模式的相关性。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.01894-17. Print 2018 Apr 1.
3
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.
4
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
5
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.V3特异性抗体在涉及1型人类免疫缺陷病毒原始毒株和实验室适应毒株的中和试验中的不同作用。
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1379-91. doi: 10.1089/aid.1995.11.1379.
6
Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.模仿HIV-1 gp120中除V3环以外的特定二硫键环的肽不会引发病毒中和抗体。
AIDS Res Hum Retroviruses. 1991 Aug;7(8):657-62. doi: 10.1089/aid.1991.7.657.
7
Regulation of the susceptibility of HIV-1 to a neutralizing antibody KD-247 by nonepitope mutations distant from its epitope.非表位突变远距离调节 HIV-1 对中和抗体 KD-247 的敏感性。
AIDS. 2011 Nov 28;25(18):2209-16. doi: 10.1097/QAD.0b013e32834bab68.
8
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
9
V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system.使用FHV表位呈递系统对HIV-1感染患者进行V3环核心区域血清分型
J Virol Methods. 1997 Jan;63(1-2):121-7. doi: 10.1016/s0166-0934(96)02120-9.
10
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.对V3构象敏感表位具有特异性的人源单克隆抗体可中和来自不同进化枝的1型人类免疫缺陷病毒原始分离株。
J Virol. 2002 Sep;76(18):9035-45. doi: 10.1128/jvi.76.18.9035-9045.2002.

引用本文的文献

1
Arg18 Substitutions Reveal the Capacity of the HIV-1 Capsid Protein for Non-Fullerene Assembly.Arg18 取代揭示了 HIV-1 衣壳蛋白的非富勒烯组装能力。
Viruses. 2024 Jun 27;16(7):1038. doi: 10.3390/v16071038.
2
HIV-1 capsids enter the FG phase of nuclear pores like a transport receptor.HIV-1 衣壳进入核孔的 FG 相,就像一种运输受体。
Nature. 2024 Feb;626(8000):843-851. doi: 10.1038/s41586-023-06966-w. Epub 2024 Jan 24.
3
Structural insights into HIV-1 polyanion-dependent capsid lattice formation revealed by single particle cryo-EM.

本文引用的文献

1
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.抗体和 TLR7 激动剂可延缓感染 SHIV 的猴子体内病毒反弹。
Nature. 2018 Nov;563(7731):360-364. doi: 10.1038/s41586-018-0600-6. Epub 2018 Oct 3.
2
Inositol phosphates are assembly co-factors for HIV-1.肌醇磷酸是 HIV-1 的组装协同因子。
Nature. 2018 Aug;560(7719):509-512. doi: 10.1038/s41586-018-0396-4. Epub 2018 Aug 1.
3
Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine.广泛中和抗体的结构特征与疫苗的合理设计。
通过单颗粒冷冻电镜解析揭示 HIV-1 多阴离子依赖的衣壳晶格形成的结构见解。
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2220545120. doi: 10.1073/pnas.2220545120. Epub 2023 Apr 24.
4
Modeling HIV-1 nuclear entry with nucleoporin-gated DNA-origami channels.用核孔蛋白门控 DNA 折纸通道模拟 HIV-1 核进入。
Nat Struct Mol Biol. 2023 Apr;30(4):425-435. doi: 10.1038/s41594-023-00925-9. Epub 2023 Feb 20.
5
Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.可视化 HIV-1 衣壳及其与抗病毒药物和宿主因子的相互作用。
Viruses. 2021 Feb 4;13(2):246. doi: 10.3390/v13020246.
6
RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines.RhCMV 血清状态和疫苗佐剂影响 RhCMV/SIV 疫苗的免疫原性。
Sci Rep. 2020 Aug 20;10(1):14056. doi: 10.1038/s41598-020-71075-x.
Adv Exp Med Biol. 2018;1075:73-95. doi: 10.1007/978-981-13-0484-2_4.
4
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.基于表位的疫苗设计产生了靶向融合肽的抗体,这些抗体能够中和多种 HIV-1 毒株。
Nat Med. 2018 Jun;24(6):857-867. doi: 10.1038/s41591-018-0042-6. Epub 2018 Jun 4.
5
Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine.多价抗原呈递增强了合成三组分HIV-1 V3糖肽疫苗的免疫原性。
ACS Cent Sci. 2018 May 23;4(5):582-589. doi: 10.1021/acscentsci.8b00060. Epub 2018 May 7.
6
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.基于抗体鉴定、B 细胞发生和表位结构的 HIV-1 疫苗。
Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.
7
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.MotionCor2:用于改进冷冻电子显微镜的束流诱导运动的各向异性校正
Nat Methods. 2017 Apr;14(4):331-332. doi: 10.1038/nmeth.4193. Epub 2017 Feb 27.
8
Polyvalent vaccine approaches to combat HIV-1 diversity.应对HIV-1多样性的多价疫苗策略。
Immunol Rev. 2017 Jan;275(1):230-244. doi: 10.1111/imr.12516.
9
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.鼻内接种具有复制能力的仙台病毒载体1型人类免疫缺陷病毒(HIV-1) gag疫苗的安全性和免疫原性的首次人体评估:在初免-加强免疫方案中诱导强效T细胞或抗体反应
J Infect Dis. 2017 Jan 1;215(1):95-104. doi: 10.1093/infdis/jiw500. Epub 2016 Oct 17.
10
The structure and flexibility of conical HIV-1 capsids determined within intact virions.完整 HIV-1 衣壳的结构和柔韧性在完整病毒中确定。
Science. 2016 Dec 16;354(6318):1434-1437. doi: 10.1126/science.aah4972.